215 related articles for article (PubMed ID: 1445258)
1. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):131-5. PubMed ID: 1445258
[TBL] [Abstract][Full Text] [Related]
2. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
Bateman JF; Hannagan M; Chan D; Cole WG
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
[TBL] [Abstract][Full Text] [Related]
4. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
[TBL] [Abstract][Full Text] [Related]
5. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
Yang W; Battineni ML; Brodsky B
Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
[TBL] [Abstract][Full Text] [Related]
6. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
[TBL] [Abstract][Full Text] [Related]
7. Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.
Wang Q; Orrison BM; Marini JC
J Biol Chem; 1993 Nov; 268(33):25162-7. PubMed ID: 7693712
[TBL] [Abstract][Full Text] [Related]
8. Moderately severe osteogenesis imperfecta associated with substitutions of serine for glycine in the alpha 1(I) chain of type I collagen.
Marini JC; Lewis MB; Chen K
Am J Med Genet; 1993 Jan; 45(2):241-5. PubMed ID: 8456809
[TBL] [Abstract][Full Text] [Related]
9. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
Cabral WA; Chernoff EJ; Marini JC
Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
[TBL] [Abstract][Full Text] [Related]
10. Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene.
Mottes M; Sangalli A; Valli M; Gomez Lira M; Tenni R; Buttitta P; Pignatti PF; Cetta G
Hum Genet; 1992 Jul; 89(5):480-4. PubMed ID: 1634225
[TBL] [Abstract][Full Text] [Related]
11. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
[TBL] [Abstract][Full Text] [Related]
12. A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III.
Rose NJ; Mackay K; Byers PH; Dalgleish R
Hum Genet; 1995 Feb; 95(2):215-8. PubMed ID: 7860070
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
14. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
15. Glycine to tryptophan substitution in type I collagen in a patient with OI type III: a unique collagen mutation.
Nuytinck L; Tükel T; Kayserili H; Apak MY; De Paepe A
J Med Genet; 2000 May; 37(5):371-5. PubMed ID: 10807697
[TBL] [Abstract][Full Text] [Related]
16. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
17. Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutions.
Baker AT; Ramshaw JA; Chan D; Cole WG; Bateman JF
Biochem J; 1989 Jul; 261(1):253-7. PubMed ID: 2775212
[TBL] [Abstract][Full Text] [Related]
18. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
[TBL] [Abstract][Full Text] [Related]
19. Substitution of aspartic acid for glycine at position 310 in type II collagen produces achondrogenesis II, and substitution of serine at position 805 produces hypochondrogenesis: analysis of genotype-phenotype relationships.
Bonaventure J; Cohen-Solal L; Ritvaniemi P; Van Maldergem L; Kadhom N; Delezoide AL; Maroteaux P; Prockop DJ; Ala-Kokko L
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):823-30. PubMed ID: 7741714
[TBL] [Abstract][Full Text] [Related]
20. NMR conformational and dynamic consequences of a gly to ser substitution in an osteogenesis imperfecta collagen model peptide.
Li Y; Brodsky B; Baum J
J Biol Chem; 2009 Jul; 284(31):20660-7. PubMed ID: 19451653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
